The CDC and the FDA are now investigating reports of six rare blood clots in women between the ages of 18 and 48 after they got the Johnson & Johnson vaccine between six and 13 days earlier. As the investigation is carried out, the New Jersey Health Department has announced that the vaccines from the New Jersey-based company will not be administered in the Garden State until further notice out of an abundance of caution. Dr. Reynold Panettieri, vice chancellor and director at the Rutgers Institute for Translational Medicine and Science and a professor at the Robert Wood Johnson Medical School, believes this pause is the right course of action. To read the full story.